Szabo ST - Search Results

1

Enrichment using speech latencies improves treatment effect size in a clinical trial of bipolar depression.

Siegel JS, Cohen AS, Szabo ST, Tomioka S, Opler M, Kirkpatrick B, Hopkins S. Siegel JS, et al. Among authors: szabo st. Psychiatry Res. 2024 Oct;340:116105. doi: 10.1016/j.psychres.2024.116105. Epub 2024 Aug 3. Psychiatry Res. 2024. PMID: 39151277 Clinical Trial.

2

Evaluating speech latencies during structured psychiatric interviews as an automated objective measure of psychomotor slowing.

Cohen AS, Rodriguez Z, Opler M, Kirkpatrick B, Milanovic S, Piacentino D, Szabo ST, Tomioka S, Ogirala A, Koblan KS, Siegel JS, Hopkins S. Cohen AS, et al. Among authors: szabo st. Psychiatry Res. 2024 Oct;340:116104. doi: 10.1016/j.psychres.2024.116104. Epub 2024 Aug 6. Psychiatry Res. 2024. PMID: 39137558 Clinical Trial.

3

A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depression.

Hopkins SC, Tomioka S, Szabo ST, Koblan KS. Hopkins SC, et al. Among authors: szabo st. Contemp Clin Trials. 2024 Oct;145:107644. doi: 10.1016/j.cct.2024.107644. Epub 2024 Aug 3. Contemp Clin Trials. 2024. PMID: 39098761

4

Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain.

Hopkins SC, Toongsuwan S, Corriveau TJ, Watanabe T, Tsushima Y, Asada T, Lew R, Shi L, Zann V, Snowden TJ, van der Graaf PH, Darpo B, Searle GE, Rabiner EA, Wilding I, Szabo ST, Galluppi GR, Koblan KS. Hopkins SC, et al. Among authors: szabo st. Clin Pharmacol Ther. 2024 Aug;116(2):460-470. doi: 10.1002/cpt.3311. Epub 2024 May 31. Clin Pharmacol Ther. 2024. PMID: 38822554

5

Estimating heterogeneity of treatment effect in psychiatric clinical trials.

Siegel JS, Zhong J, Tomioka S, Ogirala A, Faraone SV, Szabo ST, Koblan KS, Hopkins SC. Siegel JS, et al. Among authors: szabo st. medRxiv [Preprint]. 2024 Apr 23:2024.04.23.24306211. doi: 10.1101/2024.04.23.24306211. medRxiv. 2024. PMID: 38712180 Free PMC article. Preprint.

6

A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy.

Szabo ST, Hopkins SC, Lew R, Loebel A, Roth T, Koblan KS. Szabo ST, et al. Sleep Med. 2023 Jul;107:202-211. doi: 10.1016/j.sleep.2023.04.019. Epub 2023 Apr 28. Sleep Med. 2023. PMID: 37209427 Free article. Clinical Trial.

7

Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches.

Crofton KM, Bassan A, Behl M, Chushak YG, Fritsche E, Gearhart JM, Marty MS, Mumtaz M, Pavan M, Ruiz P, Sachana M, Selvam R, Shafer TJ, Stavitskaya L, Szabo DT, Szabo ST, Tice RR, Wilson D, Woolley D, Myatt GJ. Crofton KM, et al. Among authors: szabo st. Comput Toxicol. 2022 May;22:100223. doi: 10.1016/j.comtox.2022.100223. Epub 2022 Mar 17. Comput Toxicol. 2022. PMID: 35844258 Free PMC article.

8

Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress.

Kritzer MD, Mischel NA, Young JR, Lai CS, Masand PS, Szabo ST, Mathew SJ. Kritzer MD, et al. Among authors: szabo st. Ann Clin Psychiatry. 2022 Feb;34(1):33-43. doi: 10.12788/acp.0048. Ann Clin Psychiatry. 2022. PMID: 35166663 Free PMC article. Review.

9

Enhancing cognitive restructuring with concurrent fMRI-guided neurostimulation for emotional dysregulation-A randomized controlled trial.

Neacsiu AD, Beynel L, Graner JL, Szabo ST, Appelbaum LG, Smoski MJ, LaBar KS. Neacsiu AD, et al. Among authors: szabo st. J Affect Disord. 2022 Mar 15;301:378-389. doi: 10.1016/j.jad.2022.01.053. Epub 2022 Jan 14. J Affect Disord. 2022. PMID: 35038479 Free PMC article. Clinical Trial.

10

Enhancing Cognitive Restructuring with Concurrent Repetitive Transcranial Magnetic Stimulation: A Transdiagnostic Randomized Controlled Trial.

Neacsiu AD, Beynel L, Powers JP, Szabo ST, Appelbaum LG, Lisanby SH, LaBar KS. Neacsiu AD, et al. Among authors: szabo st. Psychother Psychosom. 2022;91(2):94-106. doi: 10.1159/000518957. Epub 2021 Sep 22. Psychother Psychosom. 2022. PMID: 34551415 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters